cannabinoid drugs for Dravet Syndrome
2 tracked cannabinoid drugs in the Dravet Syndrome race. The class explanation lives on the cannabinoid page; the full indication pipeline across every mechanism is on the Dravet Syndrome page.
1 approved / phase 41 preclinical / unstaged
Head-to-head evidence: Cannabidiol (Epidiolex) vs Cannabidiol (Kanbis)